K.J. Harrison & Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $952K | Sell |
1,898
-40
| -2% | -$19.2K | 0.13% | 138 |
|
|
2026
Q1 | $953K | Sell |
1,938
-3,010
| -61% | -$1.63M | 0.16% | 138 |
|
|
2025
Q4 | $2.87M | Buy |
4,948
+1,070
| +28% | +$605K | 0.38% | 80 |
|
|
2025
Q3 | $2.04M | Buy |
3,878
+1,500
| +63% | +$698K | 0.29% | 93 |
|
|
2025
Q2 | $964K | Sell |
2,378
-33
| -1% | -$13.8K | 0.16% | 123 |
|
|
2025
Q1 | $1.2M | Buy |
2,411
+10
| +0.4% | +$5.42K | 0.23% | 107 |
|
|
2024
Q4 | $1.25M | Sell |
2,401
-1,977
| -45% | -$1.09M | 0.2% | 112 |
|
|
2024
Q3 | $2.61M | Sell |
4,378
-35
| -0.8% | -$20.7K | 0.39% | 69 |
|
|
2024
Q2 | $2.44M | Buy |
4,413
+46
| +1% | +$26.4K | 0.4% | 67 |
|
|
2024
Q1 | $2.54M | Sell |
4,367
-810
| -16% | -$455K | 0.39% | 72 |
|
|
2023
Q4 | $2.75M | Buy |
+5,177
| New | +$2.51M | 0.47% | 64 |
|
|
2023
Q3 | – | Sell |
-6,096
| Closed | -$3.17M | – | 202 |
|
|
2023
Q2 | $3.17M | Buy |
6,096
+1,110
| +22% | +$599K | 0.57% | 58 |
|
|
2023
Q1 | $2.87M | Hold |
4,986
| – | – | 0.58% | 53 |
|
|
2022
Q4 | $3.72M | Hold |
4,986
| – | – | 0.73% | 40 |
|
|
2022
Q3 | $2.53M | Buy |
4,986
+280
| +6% | +$157K | 0.89% | 33 |
|
|
2022
Q2 | $2.56M | Sell |
4,706
-4,150
| -47% | -$2.28M | 0.69% | 41 |
|
|
2022
Q1 | $5.23M | Sell |
8,856
-1,468
| -14% | -$843K | 0.84% | 29 |
|
|
2021
Q4 | $6.9M | Sell |
10,324
-1,452
| -12% | -$907K | 0.98% | 21 |
|
|
2021
Q3 | $6.77M | Hold |
11,776
| – | – | 0.98% | 21 |
|
|
2021
Q2 | $5.95M | Sell |
11,776
-482
| -4% | -$227K | 0.62% | 26 |
|
|
2021
Q1 | $5.59M | Sell |
12,258
-3,310
| -21% | -$1.58M | 0.86% | 25 |
|
|
2020
Q4 | $7.25M | Sell |
15,568
-2,700
| -15% | -$1.27M | 1.18% | 14 |
|
|
2020
Q3 | $8.07M | Buy |
18,268
+6,450
| +55% | +$2.66M | 1.67% | 8 |
|
|
2020
Q2 | $4.28M | Buy |
11,818
+78
| +0.7% | +$26.1K | 1.17% | 20 |
|
|
2020
Q1 | $3.33M | Sell |
11,740
-7,860
| -40% | -$2.48M | 1.85% | 16 |
|
|
2019
Q4 | $6.37M | Sell |
19,600
-2,900
| -13% | -$879K | 1.6% | 10 |
|
|
2019
Q3 | $6.55M | Buy |
22,500
+4,500
| +25% | +$1.29M | 1.82% | 8 |
|
|
2019
Q2 | $5.29M | Buy |
18,000
+5,000
| +38% | +$1.38M | 1.68% | 11 |
|
|
2019
Q1 | $3.56M | Buy |
13,000
+1,000
| +8% | +$249K | 1.24% | 23 |
|
|
2018
Q4 | $2.69M | Sell |
12,000
-3,000
| -20% | -$704K | 1.64% | 21 |
|
|
2018
Q3 | $3.66M | Buy |
+15,000
| New | +$3.45M | 0.94% | 32 |
|
Other funds holding TMO
K.J. Harrison & Partners's TMO Position: Q2 2026 in Review
K.J. Harrison & Partners reduced its Thermo Fisher Scientific (TMO) stake by 2.1% in Q2 2026, selling an estimated $19.2K and leaving 1,898 shares worth $952K. The position accounts for 0.13% of the portfolio, ranked #138.
K.J. Harrison & Partners first reported a position in TMO in Q3 2018 and has held it in 31 quarters since. The position peaked at $8.07M in Q3 2020. 2,623 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- K.J. Harrison & Partners held 1,898 shares of Thermo Fisher Scientific worth $952K as of Q2 2026.
- K.J. Harrison & Partners sold 40 Thermo Fisher Scientific shares in Q2 2026, an estimated $19.2K.
- Thermo Fisher Scientific made up 0.13% of K.J. Harrison & Partners's portfolio in Q2 2026, its #138 holding.
- K.J. Harrison & Partners first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 31 quarters since.
- K.J. Harrison & Partners's Thermo Fisher Scientific position peaked at $8.07M in Q3 2020.
- 2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on K.J. Harrison & Partners's 13F filing for Q2 2026, filed 7 Aug 2026.